OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activation of the IL-4/STAT6 Signaling Pathway Promotes Lung Cancer Progression by Increasing M2 Myeloid Cells
Cuiping Fu, Liyan Jiang, Shengyu Hao, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy
Amrita Basu, Ganesan Ramamoorthi, Gabriella Albert, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 216

Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting
Qindong Zhang, Mouldy Sioud
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7493-7493
Open Access | Times Cited: 132

Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy
Yu-Chen Wang, Xi Wang, Jiaji Yu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 113

Tumor-associated macrophages: an effective player of the tumor microenvironment
Udit Basak, Tania Sarkar, Sumon Mukherjee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 86

Polysaccharides regulate Th1/Th2 balance: A new strategy for tumor immunotherapy
Qihang Shang, Xiaoyun Yu, Qi Sun, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115976-115976
Open Access | Times Cited: 44

Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy
Belén Toledo, Linrui Zhu Chen, María Paniagua-Sancho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 44

STAT6: A review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology
Georgia Karpathiou, Alexandra Papoudou‐Bai, Elise Ferrand, et al.
Pathology - Research and Practice (2021) Vol. 223, pp. 153477-153477
Open Access | Times Cited: 68

Involvement of IL-4, IL-13 and Their Receptors in Pancreatic Cancer
Jingwei Shi, Xujun Song, Benno Traub, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2998-2998
Open Access | Times Cited: 57

Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications
Hyun-Jung Park, S.-H. Lee, Jaehun Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13764-13764
Open Access | Times Cited: 25

Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti–PD-1 in Metastatic Non–Small Cell Lung Cancer
Kewen He, Hampartsoum B. Barsoumian, Nahum Puebla‐Osorio, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 4, pp. 486-500
Open Access | Times Cited: 23

Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy
Birgit Fendl, Anna S. Berghoff, Matthias Preusser, et al.
ESMO Open (2023) Vol. 8, Iss. 1, pp. 100776-100776
Open Access | Times Cited: 23

Exosomal miR-200b-3p induce macrophage polarization by regulating transcriptional repressor ZEB1 in hepatocellular carcinoma
Ying Xu, Guangchao Luan, Feng Liu, et al.
Hepatology International (2023) Vol. 17, Iss. 4, pp. 889-903
Closed Access | Times Cited: 23

A review of natural products targeting tumor immune microenvironments for the treatment of lung cancer
Pengyu Yao, Liang Su, Zhenying Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8

Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy
Keywan Mortezaee, Jamal Majidpoor
Cellular Oncology (2022) Vol. 45, Iss. 3, pp. 333-353
Closed Access | Times Cited: 37

STAT6 contributes to renal fibrosis by modulating PPARα-mediated tubular fatty acid oxidation
Jianzhong Li, Youjing Yang, Qianmin Li, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 31

Metabolites and Immune Response in Tumor Microenvironments
Salvatore Cortellino, Valter D. Longo
Cancers (2023) Vol. 15, Iss. 15, pp. 3898-3898
Open Access | Times Cited: 17

From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 7

Tumor-associated macrophages affect the treatment of lung cancer
Zhuchen Yu, Juntao Zou, Fei Xu
Heliyon (2024) Vol. 10, Iss. 7, pp. e29332-e29332
Open Access | Times Cited: 6

STAT4 and STAT6, their role in cellular and humoral immunity and in diverse human diseases
Manlio Tolomeo, Antonio Cascio
International Reviews of Immunology (2024) Vol. 43, Iss. 6, pp. 394-418
Closed Access | Times Cited: 6

TGR5 deficiency activates antitumor immunity in non-small cell lung cancer via restraining M2 macrophage polarization
Lifang Zhao, Hongyan Zhang, Xueqing Liu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 787-800
Open Access | Times Cited: 36

Multi-omic analyses of m5C readers reveal their characteristics and immunotherapeutic proficiency
Rui Xu, Yue Wang, Ye Kuang
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5

Roles of IL-4, IL-13, and Their Receptors in Lung Cancer
Yao Zhang, Kangle Zhu, Xiao Wang, et al.
Journal of Interferon & Cytokine Research (2024) Vol. 44, Iss. 9, pp. 399-407
Closed Access | Times Cited: 4

Page 1 - Next Page

Scroll to top